Press Releases

Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows

Indica Labs and Hamamatsu Photonics K.K. have announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale

Creative Peptides announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.

BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

EKF introduces hand-held hemoglobin analyzer with secure POC connectivity

DiaSpect Tm POC hemoglobin analyzer now powered by EKF Link digital connectivity solution

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

Diagnostics for the Real World’s multiplex respiratory virus rapid point-of-care tests approved for sale in New Zealand

Diagnostics for the Real World Ltd (DRW), innovator of the SAMBA platform for rapid point-of-care detection of infectious diseases, today announces that it has received formal authorisation from the New Zealand government for the sale and distribution of its highly accurate molecular SAMBA II SARS-CoV-2 test, plus its new SAMBA II SARS-CoV-2/FluA/FluB and SAMBA II SARS-CoV-2/RSV multiplex tests – delivering transformative, rapid respiratory infection control capabilities to the country’s healthcare providers.

SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS

Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide

Absolute Biotech launched today as a unified company joining together leading antibody-centric brands: Absolute Antibody, LSBio, Kerafast, Nordic-MUBio, Everest Biotech and Exalpha from around the world.

Biotium’s New Laser Diode Gel Illuminator Offers a Superior Alternative to LED and UV-based Illumination

Biotium has announced the release of the next-generation Gel-Bright™ Laser Diode Gel Illuminator, offering a better alternative to UV and LED-based gel imaging.

LIQUID STABLE, MULTI-LEVEL CLINICAL REFERENCE MATERIALS FOR TOXICOLOGY TESTING AVAILABLE FROM VERICHEM LABOTATORIES

VERICHEM has announced the availability of ready-to-use, multi-level, clinical reference materials for use with Toxicology assays on a wide array of clinical testing systems.

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.

Epilepsy patients set to benefit from non-invasive, real-time molecular breath analysis

Deep Breath Intelligence is pleased to announce the launch of DBI-EPIbreath®, a simple breath test that can provide reliable estimates of circulating concentrations of the antiseizure medication (ASM) valproic acid to aid patient management.

New resources from PATH & Accenture: Strengthening diagnostics supply security with local manufacturing and market-shaping interventions

Heart pacing company Ceryx Medical partners with Osypka Medical

Ceryx Medical Limited has announced a partnership with Berlin-based Osypka Medical to develop a heart pacing device that will change the way patients with heart failure and other cardiac conditions are treated.

DispatchHealth and Pathnostics Initiate Clinical Study to Compare Guidance UTI® Test to Standard Urine Culture Among Patients Receiving In-Home Care

Here is a link to the press release: https://www.prnewswire.com/news-releases/dispatchhealth-and-pathnostics-initiate-clinical-study-to-compare-guidance-uti-test-to-standard-urine-culture-among-patients-receiving-in-home-care-301634914.html?tc=eml_cleartime

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Blue Earth Diagnostics announced that the FDA has accepted its filing for a New Drug Application for 18F-rhPSMA-7.3, an investigational radiohybrid Prostate-Specific Membrane Antigen-targeted (PSMA) PET imaging agent. The submission is for the use of 18F-rhPSMA-7.3 PET for diagnostic imaging of prostate cancer.

CD BioGlyco Supports Glycan Separation and Purification with Advanced Techniques

Profacgen Enhanced Its Structure-based Virtual Screening (SBVS) Service Recently